This bill reauthorizes the Young Women’s Breast Health Education and Awareness program through 2031, extending its authorization period by five years (from 2026 to 2031). It directly affects the existing program established under the 2009 law, which provides funding for breast health education and awareness initiatives targeting young women. The key provision is a simple date amendment in the Public Health Service Act to update the program’s expiration date. As a procedural reauthorization, it does not create new policies or alter program requirements.
This resolution expresses the House of Representatives' support for the United States ratifying the Rome Statute to become a full member of the International Criminal Court. The bill calls for lifting current sanctions and visa restrictions on ICC personnel and encourages the U.S. to persuade other nations to join the court. It frames joining the court as a way to uphold American values of justice and accountability while allowing the U.S. to influence the court's priorities.
This resolution asks the President and the Secretary of Health and Human Services to provide the House of Representatives with specific documents regarding a freeze on federal payments to five states. The requested materials include communications about how the payment freeze was decided, records of the tweet that announced it, and details on funding drawdowns, disciplinary actions, and data sharing plans related to those states. The bill specifically targets documents concerning Temporary Assistance for Needy Families, Child Care, and Social Services Block Grant programs in California, Colorado, Illinois, Minnesota, and New York. If the agencies possess the records, they must submit them to Congress within 14 days of the resolution's adoption.
The SEARCH Act of 2026 targets large search engine and AI companies with over 40% of U.S. users to prevent them from favoring their own services or blocking competitors. It prohibits these platforms from paying for exclusive deals, forcing publishers to use their ads, or bundling their search tools with devices and browsers. The law also requires major platforms to share their search data and ad information with qualified competitors at low cost and to offer users a neutral choice screen to select default search engines. Additionally, the bill mandates that advertisers receive detailed reports on their campaigns and that platforms license their search results to rivals without restrictions. The Federal Trade Commission will enforce these rules, with penalties reaching up to 15% of a company's annual revenue for violations.
The Cancer Drug Parity Act of 2026 requires group health plans and insurance coverage to treat the cost-sharing for oral cancer medications no less favorably than that for intravenously administered cancer drugs. This rule applies to FDA-approved oral cancer treatments that a treating physician deems medically necessary and clinically appropriate, ensuring that deductibles, copayments, and coinsurance rates are not higher for oral options. The legislation also prohibits plans from making changes that would increase out-of-pocket costs or impose stricter limitations on oral cancer drugs compared to injected ones, while still allowing for standard utilization controls like prior authorization. Additionally, the bill mandates a Government Accountability Office study within two years to assess the impact of these changes on patient costs and access.
The Medicare-X Choice Act of 2026 creates a new public health plan called the Medicare Exchange health plan, which would be available to individuals and small groups starting in 2028. The bill establishes two dedicated funds to finance the plan's creation and technology updates, appropriating $1 billion each for fiscal year 2027. Under the plan, the government would set premiums to cover full costs, and reimbursement rates for doctors and hospitals would generally match current Medicare rates, with potential increases for rural areas. The legislation also requires health care providers who participate in traditional Medicare to also accept patients in this new plan, while prohibiting insurers from placing additional restrictions on enrollees. Additionally, the bill expands tax credits for people buying insurance, fixes the "family glitch" that currently limits subsidy eligibility for some workers, and authorizes the government to negotiate prices for prescription drugs.
The Drug Deal Disclosure Act requires the Department of Health and Human Services to publicly release records of specific agreements between the federal government and major drug manufacturers starting in 2025. These agreements must include provisions such as offering lower drug prices based on international rates, providing discounts through government platforms like TrumpRx, or receiving special exemptions from import duties and regulatory reviews. While the bill mandates that most documents be made available in a searchable format, it allows the government to withhold only specific confidential pricing details if legally required by foreign laws or court orders, provided a justification is published. Additionally, the law directs the Congressional Budget Office and the Government Accountability Office to analyze the economic and budgetary impacts of these deals, including effects on Medicare, Medicaid, and drug competition.
The Patients First Act of 2026 modifies how Medicare reimburses physicians and primary care providers to improve access and stabilize payments. It establishes a new hybrid payment model for primary care services from 2027 to 2031, which pays a monthly fee per patient to eligible independent practices while covering specific services like care management and telehealth without cost-sharing for patients. The bill also updates the formula for calculating reimbursement rates to account for high inflation years and requires more frequent updates to the costs used in calculating payments. Additionally, the legislation reforms the performance-based payment system by adding care efficiency measures, creating a task force to recommend new quality metrics, and adjusting penalties for providers who fail to report on certain data.
The Essential Caregivers Act of 2026 requires nursing homes, long-term care hospitals, rehabilitation facilities, and intermediate care facilities to allow two chosen family members or friends to visit residents during times when regular visitation is suspended. These essential caregivers must agree to follow the facility's existing safety and infection control rules, which are no more restrictive than those applied to staff. While facilities can limit access for the first seven days of a suspension or deny entry if a caregiver shows symptoms of a serious infectious disease, they cannot block visits for end-of-life care. Additionally, the bill mandates that complaints about denied access to essential caregivers be investigated and resolved within three days.
HR 7651, the Chloe Cole Act of 2026, prohibits healthcare providers from performing certain medical interventions on minors under 18 aimed at altering physical development to align with gender identity. These "covered interventions" include puberty blockers, hormone treatments, and specific surgeries, but exclude medically necessary care for conditions like disorders of sexual development or traumatic injuries. The bill creates a federal civil lawsuit right for affected minors or their parents against providers who perform such interventions, allowing claims for damages including emotional distress and punitive awards, with strict liability for providers after the law's enactment. It explicitly allows exceptions for legitimate medical treatments and requires providers to prove such exceptions apply if challenged.
HR 4090, the Critical Mineral Dominance Act, aims to boost U.S. production of hardrock minerals (like rare earths, base metals, and gemstones) to strengthen domestic supply chains and national security. It requires the Secretary of the Interior to submit a 90-day report analyzing the economic impact of mineral import reliance, prioritize expedited permitting for mining projects on federal land, and review regulations to remove barriers to mineral development. The bill also mandates annual reports identifying federal lands with mineral potential and accelerates geologic mapping to locate new deposits. These provisions directly affect mining companies, federal land managers, and supply chain security efforts, focusing on concrete policy actions rather than outcomes.
This bill requires Medicare Advantage plans to implement electronic pre-approval systems for medical services by 2028 and meet transparency reporting standards starting in 2027. Plans must publicly report data on approval/denial rates, appeal outcomes, response times, and technology use for pre-approval requests, including details on how denials relate to clinical criteria. It establishes a 24-hour response timeframe for certain requests and mandates annual reviews of pre-approval requirements based on data and input from seniors and providers. The law directly affects Medicare Advantage plans, seniors enrolled in these plans, and healthcare providers who submit pre-approval requests. These changes aim to make the pre-approval process faster, more transparent, and more accountable for seniors seeking covered medical services.
